Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12–23 months

被引:0
|
作者
Fred Zepp
Ulrich Behre
Klaus Kindler
Karl-Heinz Laakmann
Heidemarie Pankow-Culot
Wilma Mannhardt-Laakmann
François Beckers
Dominique Descamps
Paul Willems
机构
[1] Johannes-Gutenberg-Universität,Department of Paediatrics
[2] Paediatric Office,undefined
[3] Paediatric Office,undefined
[4] Paediatric Office,undefined
[5] Paediatric Office,undefined
[6] GlaxoSmithKline Biologicals,undefined
来源
关键词
Measles-mumps-rubella-varicella vaccine; DTPa-HBV-IPV/Hib booster; Co-administration; Immunogenicity; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
This study was undertaken to assess the co-administration of an experimental measles-mumps-rubella-varicella vaccine (MMRV, GlaxoSmithKline Biologicals) with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate (DTPa-HBV-IPV/Hib) vaccine in healthy children. Healthy children aged 12–23 months (N = 451) were randomised to one of three parallel groups to receive one dose of MMRV vaccine co-administered with a booster dose of DTPa-HBV-IPV/Hib vaccine (co-administration group), or one dose of MMRV vaccine alone (MMRV group), or a booster dose of DTPa-HBV-IPV/Hib vaccine alone (DTPa-HBV-IPV/Hib group). No differences in seroconversion rates for measles (>95%), mumps (>80%), rubella (>99%) and varicella (>98%) were seen between the co-administration group and the MMRV group. No differences in geometric mean titres (GMTs) were observed between the two groups with the exception of anti-measles titres, which were observed to be higher in the MMRV group than in the co-administration group (4,419.2 vs. 3,441.8 mIU/ml respectively). Immune response to the booster dose of DTPa-HBV-IPV/Hib vaccine was observed to be similar in the co-administration group and the DTPa-HBV-IPV/Hib group. Co-administration of the MMRV vaccine with a booster dose of DTPa-HBV-IPV/Hib vaccine was well-tolerated and did not exacerbate the reactogenicity profile of either vaccine. In summary, GlaxoSmithKline Biologicals’ experimental MMRV vaccine was immunogenic and well-tolerated when administered with a booster dose of DTPa-HBV-IPV/Hib vaccine during the second year of life. The ability to co-administer the MMRV vaccine at the same time as other routine childhood immunisation vaccines could increase compliance with varicella vaccination in countries where this vaccine is already recommended and may facilitate implementation of varicella vaccination elsewhere.
引用
收藏
页码:857 / 864
页数:7
相关论文
共 50 条
  • [1] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
    Zepp, Fred
    Behre, Ulrich
    Kindler, Klaus
    Laakmann, Karl-Heinz
    Pankow-Culot, Heidemarie
    Mannhardt-Laakmann, Wilma
    Beckers, Francois
    Descamps, Dominique
    Willems, Paul
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (08) : 857 - 864
  • [2] Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination
    Pichichero, ME
    Blatter, MM
    Reisinger, KS
    Harrison, CJ
    Johnson, CE
    Steinhoff, MC
    Senders, SD
    Rothstein, EP
    Willems, P
    Howe, BJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) : 854 - 859
  • [3] Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity
    Omenaca, Felix
    Vazquez, Liliana
    Garcia-Corbeira, Pilar
    Mesaros, Narcisa
    Hanssens, Linda
    Dolhain, Jan
    Gomez, Ivonne Puente
    Liese, Johannes
    Knuf, Markus
    [J]. VACCINE, 2018, 36 (07) : 986 - 996
  • [4] Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society
    Russo, Rocco
    Bozzola, Elena
    Villani, Alberto
    [J]. VACCINE, 2019, 37 (30) : 3944 - 3944
  • [5] Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate hepatitis-B Vaccines and combined diphtheria-tetanus-acellular pertussis vaccines
    Shinefield, H
    Black, S
    Thear, M
    Coury, D
    Reisinger, K
    Rothstein, E
    Xu, J
    Hartzel, J
    Evans, B
    Digilio, L
    Schödel, F
    Brown, MLH
    Kuter, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (04) : 287 - 292
  • [6] Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B- inactivated poliovirus-Haemophilus influenzae type b vaccine-Infanrix™ hexa
    Baldo, Vincenzo
    Bonanni, Paolo
    Castro, Marcela
    Gabutti, Giovanni
    Franco, Elisabetta
    Marchetti, Federico
    Prato, Rosa
    Vitale, Francesco
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 129 - 137
  • [7] Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months
    Usonis, V
    Meriste, S
    Bakasenas, V
    Lutsar, I
    Collard, F
    Stoffeld, A
    Tornieporth, N
    [J]. VACCINE, 2005, 23 (20) : 2602 - 2606
  • [8] Immunogenicity of a Haemophilus influenzae type b-tetanus toroid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine
    Greenberg, DP
    Wong, VK
    Partridge, S
    Chang, SJ
    Jing, JN
    Howe, BJ
    Ward, JI
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) : 1135 - 1140
  • [9] Immunogenicity and Safety of a Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate Combination Vaccine (Pentaxim™) with Hepatitis B Vaccine
    Dutta, A. K.
    Verghese, V. P.
    Pemde, H. K.
    Mathew, L. G.
    Ortiz, E.
    [J]. INDIAN PEDIATRICS, 2009, 46 (11) : 975 - 982
  • [10] Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine
    Tejedor, JC
    Omeñaca, F
    García-Sicilia, D
    Verdaguer, J
    Van Esso, D
    Esporrín, C
    Molina, V
    Muro, M
    Marés, J
    Enrubia, M
    Moraga, F
    García-Corbeira, P
    Dobbelaere, K
    Schuerman, L
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (12) : 1109 - 1115